159 filings
Page 7 of 8
8-K
1ybhjwj9q8d2juwfn ek
3 Feb 04
Genome Therapeutics Sets Price of Common Stock Offering
12:00am
8-K
t6pi6c
3 Feb 04
Genome Therapeutics Sets Price of Common Stock Offering
12:00am
8-K
jiavcaj gw
2 Feb 04
Genome Therapeutics Reports on Nasdaq Interpretation
12:00am
8-K/A
b4ds0q9q8
30 Jan 04
Other events
12:00am
8-K
uy5lausj0h4 b74ng
9 Jan 04
Genome Therapeutics and Amgen Conclude Research Agreement; Genome Therapeutics
12:00am
8-K
aw10nzyetzeaplp4
9 Jan 04
Genome Therapeutics Enters Agreement to TransferStreptococcus pneumoniae Patent Portfolio to Aventis
12:00am
8-K
rbsgi9udv60h
31 Dec 03
Other events
12:00am
8-K
vu6js3i 5xzutinxp
18 Dec 03
Other events
12:00am
8-K
quz88wna6ddg359
17 Dec 03
Other events
12:00am
8-K
ofy955q7
18 Nov 03
Form of Voting Agreement
12:00am
8-K
u77lu66o
13 Nov 03
Genome Therapeutics Reports Financial Results for Third Quarter of 2003
12:00am
8-K
1ze11q0by
16 Oct 03
Other events
12:00am
8-K
ltwg7z 2vf0e57
1 Oct 03
Genome Therapeutics Announces $9.55 Million Private Placement Financing
12:00am
8-K
b1y qca4pif
13 Aug 03
Genome Therapeutics Reports Financial Results for Second Quarter of 2003
12:00am
8-K
c57c4zfct3wgk3
13 Jun 03
Other events
12:00am
8-K
djugb8 qcgf4r17i
5 Jun 03
Other events
12:00am
8-K
ulon ff0te
14 May 03
Genome Therapeutics Reports Financial Results for First Quarter of 2003
12:00am
8-K
19321uw71uz4
2 Jan 03
Other events
12:00am
8-K/A
utl7pidk1vrtt 6qr
2 Jul 02
Changes in registrant's certifying accountant
12:00am
8-K
omqq3904 vz1bxpmtbk2
24 Jun 02
Changes in registrant's certifying accountant
12:00am